O Organon & Company
| Market Cap | $1.66B |
| P/E Ratio | 8.83 |
| Forward P/E | 1.71 |
| Dividend Yield | 1.26% |
| Beta | 0.64 |
| 52W Range | $5.70 - $14.31 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Kahn Brothers Group Kahn Brothers Group | 4.61% | $26.02M | 3,629,451 | Add 0.35% |
Insider Trading
| Insider Name of the company insider who made the trade 1 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| COX CARRIE SMITHExecutive Chair | Buy | 65,400 | $7.67 | $501.76K | 12 Nov 2025 | 13 Nov 2025 |
Frequently Asked Questions
What is OGN stock price today?
Organon & Company (OGN) is currently trading at $6.36. The stock has a 52-week range of $5.70 to $14.31 and a market capitalization of $1.66B.
Is OGN a good stock to buy in 2026?
Organon & Company has a P/E ratio of 8.8 (forward P/E: 1.7), a dividend yield of 1.26%, and 1-year performance of -55.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling OGN stock?
There have been 1 insider transactions for OGN in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has OGN stock performed over the past year?
Organon & Company (OGN) has returned -55.6% over the past 12 months. The stock traded between $5.70 and $14.31 during this period, and is currently at $6.36.
Which hedge funds own OGN (Organon & Company)?
1 tracked hedge funds currently hold OGN in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is OGN's market cap and valuation?
Organon & Company (OGN) has a market capitalization of $1.66B. The trailing P/E ratio is 8.8 and forward P/E is 1.7. The stock is classified in the Healthcare sector.
What is OGN's revenue and profitability?
Organon & Company reported revenue of $6.22B with net income of $187.00M and a profit margin of 0.03%. The stock has a beta of 0.64.
What sector is OGN in and who are its biggest institutional holders?
Organon & Company (OGN) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.